R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.
Bharathi Upadhya,Michael V. Rocco,Nicholas M. Pajewski,Timothy R. Morgan,Joseph L. Blackshear,William G Hundley,Suzanne Oparil,Elsayed Z. Soliman,Debbie L. Cohen,Craig A. Hamilton,Monique E. Cho,William J. Kostis,Vasilios Papademetriou,Carlos J. Rodriguez,Dominic S. Raj,Raymond R. Townsend,Sujethra Vasu,Sara Zamanian,Dalane W. Kitzman +18 more
TL;DR: There were fewer cardiovascular events in the intensive control group, but no significant association between the reduced events and change in LVM or any other cardiac magnetic resonance imaging measure.
Journal ArticleDOI
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
David Goldstein,Jonathan E. Rosenberg,Robert A. Figlin,Raymond R. Townsend,Lauren McCann,Christopher L. Carpenter,Lini Pandite +6 more
TL;DR: Neither hypertension nor any blood pressure elevation above baseline was associated with efficacy outcomes of pazopanib or sunitinib, and management of tyrosine kinase inhibitor-induced hypertension is unlikely to compromise outcome.
Journal Article
Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease
Amanda H. Anderson,Wei Yang,Raymond R. Townsend,Qiang Pan,Glenn M. Chertow,John W. Kusek,Jeanne Charleston,Jiang He,Radhakrishna R. Kallem,James P. Lash,Edgar R. Miller,Mahboob Rahman,Susan Steigerwalt,Matthew R. Weir,Jackson T. Wright,Harold I. Feldman +15 more
TL;DR: Time-updated SBP greater than 130 mm Hg was more strongly associated with CKD progression than analyses based on baseline SBP and those using time-updated data, respectively.
Journal ArticleDOI
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
TL;DR: An 8‐week double‐blind, randomized study of African American patients with stage 2 hypertension that compared brachial and central BP responses to combination aliskiren/hydrochlorthiazide (HCTZ) and amlodipine monotherapy suggests a new treatment option for these patients.
Journal ArticleDOI
The Attributable Burden of Hypertension: Focus on CKD
TL;DR: This overview of high blood pressure is discussed from an epidemiologic standpoint, placing it in a nephrologic perspective and discuss some of the known and speculative mechanisms that link it to kidney damage.